Search Ontology:
ChEBI

(2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(3R,4R,5S,6R)-3-Amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Term ID
CHEBI:154513
Synonyms
  • 6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-beta-D-galacto-hexopyranosyl-(1->3)-2-amino-2-deoxy-D-gluco-hexopyranose
  • Fuc(a1-2)Gal(b1-3)GlcN
  • WURCS=2.0/3,3,2/[a2122h-1x_1-5_2*N][a2112h-1b_1-5][a1221m-1a_1-5]/1-2-3/a3-b1_b2-c1
Definition
References
  • GlyGen:G89032VF
  • GlyTouCan:G89032VF
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from (2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(3R,4R,5S,6R)-3-Amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
Phenotype where environments contain (2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(3R,4R,5S,6R)-3-Amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
Phenotype modified by environments containing (2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(3R,4R,5S,6R)-3-Amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
Phenotype affecting (2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(3R,4R,5S,6R)-3-Amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
Human Disease Model